pillbase.ru

Giapreza

Active substance: angiotensin II

angiotensin II acetate

Centralised EU authorisationActive

Marketing holder: Paion Pharma GmbH

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • ANGIOTENSIN II
    INJECTION · ANGIOTENSIN II 2.5 mg/mL
    68083-553
    Gland Pharma Limited
  • Giapreza
    INJECTION · ANGIOTENSIN II 2.5 mg/mL
    68547-501
    La Jolla Pharmaceutical Company
  • Giapreza
    INJECTION · ANGIOTENSIN II .5 mg/mL
    68547-005
    La Jolla Pharmaceutical Company
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-a73e-7222-8e08-1856baa48843,01a12090-9577-7f97-96f3-d42de1ef5f54,01a1209b-ab43-72ea-9b8b-3cbfca92ce10;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004930
Registration status
Active
ATC code
C09
Sources
  • product · EMA · EMEA/H/C/004930 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004930 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004930 · Verified 2026-10-09